Latest News

Global markets have recently experienced volatility due to geopolitical tensions in the Middle East and fluctuations in energy prices, yet major indices like the Nasdaq Composite and S&P 500 have managed to post gains. Amidst these market dynamics, penny stocks continue to capture investor interest as they represent smaller or newer companies that can offer unique growth opportunities at lower price points. By focusing on those with strong balance sheets and sound fundamentals, investors may...

In the midst of geopolitical tensions and energy market volatility, global markets have shown resilience with major U.S. indices posting gains amid hopes of de-escalating conflicts in the Middle East. As smaller-cap indexes also see solid performance, investors might find opportunities in lesser-known stocks that could benefit from improving economic indicators like consumer confidence and manufacturing activity. Amid these conditions, identifying promising stocks often involves looking for...

As global markets navigate through geopolitical tensions and fluctuating energy prices, investors are keenly observing how these factors impact economic indicators like inflation and employment. Amidst this backdrop, dividend stocks can offer a measure of stability, providing income even when market conditions are volatile. A good dividend stock in the current environment is one that not only offers a reliable yield but also demonstrates resilience against economic uncertainties.

SUSS MicroTec SE's ( ETR:SMHN ) recent weak earnings report didn't cause a big stock movement. However, we believe that...

In late March 2026, Johnson & Johnson reported 52-week Phase 3 data showing its oral peptide ICOTYDE maintained high complete skin clearance rates and a consistent safety profile in adults and adolescents with moderate-to-severe plaque psoriasis, while Royalty Pharma announced a US$500 million R&D co-funding agreement to advance JNJ-4804 for autoimmune diseases. These developments highlight Johnson & Johnson’s push to build a differentiated immunology portfolio, pairing late-stage oral...

The latest move for Nuvation Bio (NUVB) centers on Europe, where the European Medicines Agency has validated the Marketing Authorisation Application for taletrectinib in advanced ROS1-positive non-small cell lung cancer. See our latest analysis for Nuvation Bio. The EMA validation comes shortly after Nuvation Bio secured global rights to safusidenib in Japan, against a backdrop of a 7 day share price return of 8.89% but a 90 day share price return decline of 48.06%, while the 1 year total...

Centene Corporation recently announced that, effective March 18, 2026, long-time finance executive and CPA Theodore Pienkos became Corporate Controller and Chief Accounting Officer, while prior controller Kate Casso moved into a new Senior Vice President role overseeing finance operations and innovation. These leadership shifts arrive as Centene faces pressure from elevated Medicaid and ACA marketplace medical costs and the company’s decision to withdraw its 2025 guidance, placing extra...

In its recently reported second quarter of fiscal 2026, AutoZone posted earnings of US$27.63 per share with net sales up 8.2% year over year, while adding 64 new stores across the U.S., Mexico, and Brazil to reach 7,774 locations worldwide. Alongside these results, the company saw gross profit improve but operating profit ease by 1.2% and inventory grow 13.1%, reflecting the cost and complexity of its expansion and inflationary pressures. With this expansion-driven inventory build and...

Why Gartner’s recognition matters for Manhattan Associates (MANH) Manhattan Associates (MANH) was again named a Leader in Gartner's Magic Quadrant for Transportation Management Systems, its eighth consecutive appearance, after launching AI Agents within its cloud-native Manhattan Active solutions for real-time supply chain operations. See our latest analysis for Manhattan Associates. Despite the Gartner recognition and AI product launches, the 30 day share price return of 11.73% and year to...

CSG Systems International (NasdaqGS:CSGS) has entered a significant partnership with ePLDT Group to support digital solutions and enterprise services in the Philippines. The collaboration extends CSG’s platform solutions into a new Southeast Asian market within the region’s information and communications technology sector. The agreement focuses on helping enterprise clients streamline and manage their digital offerings across a growing set of services. CSG Systems International, known for...

Why earnings revisions matter for McKesson (MCK) right now Recent upward revisions to McKesson (MCK) earnings estimates, together with its record of surpassing consensus EPS in recent quarters, have put fresh attention on how the company’s pharmaceutical distribution revenue story is shaping up. See our latest analysis for McKesson. McKesson’s share price has moved to US$884.28, with a 1-day share price return of 1.37% and a 90-day share price return of 6.99%. Its 1-year total shareholder...

Diodes (DIOD) has expanded its PowerDI8080-5 N-channel MOSFET line, targeting automotive and industrial uses where efficiency, compact footprints, and reliability in electric and hybrid vehicles are central design priorities for engineers. See our latest analysis for Diodes. That product launch lands against a share price that has moved to $68.58, with a 30-day share price return of 10.81% and a 1-year total shareholder return of 86.97%. However, 3 and 5-year total shareholder returns remain...

In Q4 2025, Halozyme Therapeutics reported EPS of US$0.24 and revenue of US$451.77 million, exceeding revenue expectations but falling short on earnings, while reiterating its 2026 revenue guidance, updating 2025 guidance, and appointing David Ramsay as interim CFO on March 23, 2026. Despite the mixed quarter, analysts highlighted Halozyme’s growing royalty revenues and expanding ENHANZE partnerships as key drivers behind their more optimistic outlooks. With stronger revenue performance and...

In recent months, Tenet Healthcare reported quarterly revenue of US$5.53 billion and earnings per share of US$4.70, both ahead of consensus estimates, while analysts have become more positive on its earnings outlook. An orderly transition in Tenet’s senior finance leadership, paired with consistent earnings outperformance, highlights how its financial reporting function underpins investor confidence. We’ll now examine how Tenet’s continued earnings outperformance shapes its investment...

L3Harris Technologies recently supported the historic Artemis II crewed mission to the moon by supplying more than 100 propulsion, thruster, avionics and communications elements, including RS-25 and RL10 engines, in-space course-correction thrusters, 40 advanced avionics systems and the Orion audio system. This extensive role in a high-profile lunar mission, alongside its work on infrared tracking satellites and resilient multi-orbit communications, highlights L3Harris’s deep integration in...

What EPR Properties’ recent returns say about investor sentiment EPR Properties (EPR) has drawn fresh attention after a mixed run in its recent returns, with the share price showing a 1.7% move over the past day and a 3.8% gain over the past week. Over the past month, the stock shows an 11% decline, while the past 3 months are roughly flat. Against that backdrop, investors are weighing EPR’s US$713.961 million in revenue and US$250.792 million in net income alongside its current value score...

Umicore shares react to muted near term performance Umicore (ENXTBR:UMI) is back in focus after a period where the stock has seen mixed returns, with weakness over the past 3 months and year to date, contrasting with a strong 1 year total return. See our latest analysis for Umicore. At a share price of €16.35, Umicore’s recent 90 day share price return of 16.75% and year to date share price return of 12.05% sit alongside a very strong 1 year total shareholder return of 116.88%. However, the 3...

Soft earnings didn't appear to concern Van de Velde NV's ( EBR:VAN ) shareholders over the last week. Our analysis...

In late March 2026, Cimpress plc announced a new share repurchase program authorizing the company to buy back up to US$200,000,000 of its shares following the expiry of a prior plan on March 25, 2026. This fresh authorization highlights Cimpress’ willingness to return capital to shareholders, potentially altering how investors assess its capital allocation and balance-sheet priorities. We’ll now examine how this new US$200,000,000 share repurchase authorization might reshape Cimpress’...

Structure Therapeutics recently reported encouraging Phase 2 trial results for its oral obesity drug candidate aleniglipron, coinciding with renewed attention on GLP-1 weight-loss treatments following US FDA approval of a competing therapy from Eli Lilly. The combination of promising oral obesity data and rising institutional interest highlights how Structure Therapeutics has become more central to the fast-evolving obesity treatment landscape. We’ll now examine how the promising Phase 2...

Buyback completion and what it means for Nippon Electric Glass shareholders Nippon Electric Glass (TSE:5214) has completed its recently announced share repurchase, buying back 1,259,000 shares, or 1.67% of its stock, for ¥7,914.99 million between February 6 and March 31, 2026. This completed buyback reduces the share count, which can lift metrics like earnings per share and subtly shift the balance between existing shareholders and the company’s ¥476.8b market value at the last close of...

On 28 March 2026, the European Space Agency announced that Rocket Lab’s Electron rocket successfully launched the “Daughter Of The Stars” mission from New Zealand, placing ESA’s first two “Celeste” low Earth orbit navigation demonstration satellites into a 510 km orbit. This mission, which maintained Rocket Lab’s 100% success record for national space programs and marked its 6th launch of 2026 and 85th overall, underscores the company’s growing role as a reliable commercial provider for...

If you are wondering whether DHT Holdings at US$18.66 still offers value after a strong run, this breakdown will help you size up the stock with a clear valuation lens. The share price performance has been strong, with returns of 4.1% over 7 days, 3.3% over 30 days, 58.9% year to date, and 96.8% over the past year. These kinds of moves can change how the market prices both potential and risk. Recent coverage has focused on DHT Holdings as part of wider discussions about oil and gas shipping...

Spectra Systems Corporation ( LON:SPSY ) just reported some strong earnings, and the market reacted accordingly with a...